Steve Mullin

524 total citations
7 papers, 283 citations indexed

About

Steve Mullin is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases. According to data from OpenAlex, Steve Mullin has authored 7 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Medicine, 3 papers in Pharmacology and 2 papers in Infectious Diseases. Recurrent topics in Steve Mullin's work include Antibiotic Resistance in Bacteria (5 papers), Cancer therapeutics and mechanisms (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Steve Mullin is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Cancer therapeutics and mechanisms (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Steve Mullin collaborates with scholars based in United States, Switzerland and China. Steve Mullin's co-authors include Trudy H. Grossman, Nagraj Mani, Anne‐Laure Grillot, Christian H. Gross, Jonathan D. Parsons, Yusheng Liao, Dean Stamos, Paul S. Charifson, Eric R. Olson and Ute Müh and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters and The Journal of Antibiotics.

In The Last Decade

Steve Mullin

7 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Mullin United States 6 180 117 92 63 58 7 283
Janelle Comita-Prevoir United States 9 192 1.1× 120 1.0× 51 0.6× 74 1.2× 98 1.7× 9 330
A. Rojas-Altuve Spain 4 161 0.9× 126 1.1× 153 1.7× 57 0.9× 54 0.9× 7 340
Gagandeep Narula United States 11 204 1.1× 41 0.4× 64 0.7× 69 1.1× 110 1.9× 17 367
Jeffrey Fernandez United States 14 123 0.7× 40 0.3× 97 1.1× 67 1.1× 56 1.0× 26 333
Shajila Siricilla United States 11 229 1.3× 50 0.4× 131 1.4× 54 0.9× 119 2.1× 17 382
Kenneth DenBleyker United States 9 138 0.8× 55 0.5× 65 0.7× 99 1.6× 144 2.5× 11 343
Anne‐Laure Grillot United States 8 228 1.3× 91 0.8× 58 0.6× 42 0.7× 168 2.9× 10 338
Joanna Bryant United States 5 144 0.8× 46 0.4× 69 0.8× 39 0.6× 61 1.1× 6 298
Kunio Inoue Japan 7 170 0.9× 55 0.5× 122 1.3× 61 1.0× 68 1.2× 10 290
Varvara Pokrovskaya Israel 8 259 1.4× 92 0.8× 49 0.5× 74 1.2× 117 2.0× 8 388

Countries citing papers authored by Steve Mullin

Since Specialization
Citations

This map shows the geographic impact of Steve Mullin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Mullin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Mullin more than expected).

Fields of papers citing papers by Steve Mullin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Mullin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Mullin. The network helps show where Steve Mullin may publish in the future.

Co-authorship network of co-authors of Steve Mullin

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Mullin. A scholar is included among the top collaborators of Steve Mullin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Mullin. Steve Mullin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
LaMarche, Matthew J., et al.. (2011). 4-Aminothiazolyl analogs of GE2270 A: Design, synthesis and evaluation of imidazole analogs. Bioorganic & Medicinal Chemistry Letters. 21(11). 3210–3215. 15 indexed citations
2.
Rothstein, David M., et al.. (2008). Rifalazil and Derivative Compounds Show Potent Efficacy in a Mouse Model of H. pylori Colonization. The Journal of Antibiotics. 61(8). 485–488. 2 indexed citations
3.
Grossman, Trudy H., Steve Mullin, Christian H. Gross, et al.. (2006). Dual Targeting of GyrB and ParE by a Novel Aminobenzimidazole Class of Antibacterial Compounds. Antimicrobial Agents and Chemotherapy. 51(2). 657–666. 69 indexed citations
4.
Rothstein, David M., Angelia A. Doye, Judith K. Gwathmey, et al.. (2006). Efficacy of Novel Rifamycin Derivatives against Rifamycin-Sensitive and -Resistant Staphylococcus aureus Isolates in Murine Models of Infection. Antimicrobial Agents and Chemotherapy. 50(11). 3658–3664. 14 indexed citations
5.
Mani, Nagraj, Christian H. Gross, Jonathan D. Parsons, et al.. (2006). In Vitro Characterization of the Antibacterial Spectrum of Novel Bacterial Type II Topoisomerase Inhibitors of the Aminobenzimidazole Class. Antimicrobial Agents and Chemotherapy. 50(4). 1228–1237. 64 indexed citations
6.
Murphy, Christopher K., Steve Mullin, Marcia S. Osburne, et al.. (2006). In Vitro Activity of Novel Rifamycins against Rifamycin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 50(3). 827–834. 36 indexed citations
7.
Mullin, Steve, Nagraj Mani, & Trudy H. Grossman. (2004). Inhibition of Antibiotic Efflux in Bacteria by the Novel Multidrug Resistance Inhibitors Biricodar (VX-710) and Timcodar (VX-853). Antimicrobial Agents and Chemotherapy. 48(11). 4171–4176. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026